Vertex Pharmaceuticals (NASDAQ: VRTX) fell by 13% on Dec. 19, when the rare-disease drug developer reported some lackluster ...

This was the stock's fourth consecutive day of gains.

Equities researchers at Zacks Research upped their Q3 2025 earnings per share estimates for shares of Vertex Pharmaceuticals ...

NEW YORK, NY / ACCESSWIRE / December 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex ...

Dow Jones futures fell modestly early Friday, along with S&P 500 futures and Nasdaq futures.The stock market rally shrugged ...

The Food and Drug Administration (FDA) has approved Alyftrek ™ (vanzacaftor/tezacaftor/deutivacaftor) for the treatment of cystic fibrosis (CF) in patients aged 6 years and older who have at least one ...

JMP Securities raised the firm’s price target on Rhythm Pharmaceuticals (RYTM) to $75 from $64 and keeps an Outperform rating on the shares as part of a broader note on Biotechnology.

PASADENA, Calif., December 23, 2024--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has dosed the first subjects in a Phase 1/2a clinical trial of ARO-INHBE, the company ...

This year, STAT published a cornucopia of stories on health and medicine, bringing our signature analysis, insight, and ...

The main opposition Democratic Party (DP) submitted an impeachment motion against acting President Han Duck-soo and reported it to a parliamentary plenary session Thursday. The ... The ...

A 10 year old Thai boy tragically died after an old rusty football goal crossbar fatally struck him on the head at his school in the Wichit sub-district of Phuket . Facebook page Phuket Info Center ...

Venmax Drugs & Pharmaceuticals Ltd. share price moved up by 4.97% from its previous close of Rs 14.86. Venmax Drugs & Pharmaceuticals Ltd. stock last traded price is 15.60 ...